Hycor Biomedical

Hycor Biomedical is a medical device company that provides in vitro diagnostic products. The company is committed to offering clinicians the highest value products through innovation, reliability, and customer service. The HYCOR system is designed to address common issues faced by laboratory personnel with current technologies. In response to the COVID-19 pandemic, HYCOR Biomedical collaborated with NaGene Diagnosis to develop a multiplex real-time PCR kit for detecting 2019-nCoV. The particle allergen testing design offers excellent capabilities for small sample sizes and large surface areas of paramagnetic particles, minimizing interference and non-specific binding. Its product, HYTEC 288 Plus, is a fully automated immunoassay instrument used for allergy testing and user-defined ELISA commercialization or assay development. It also complies with FDA Quality System Regulations, current international ISO standards, NCCLS guidelines, and CE marking requirements.